According to the latest report by IMARC Group “Aortic Valve Replacement Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The global aortic valve replacement market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 11.4% during 2021-2026.
The technique of replacing a non-functioning valve with an artificial heart valve is known as aortic valve replacement. Aortic valves are one of four valves that regulate blood flow through the heart. It connects the left ventricle to the primary artery that delivers oxygen-rich blood to the aorta. Improper aortic valve function disrupts blood flow and pushes the heart to work harder. Aortic valve replacement restores regular blood flow, alleviates symptoms, extends life, and maintains healthy heart muscle function. Prosthetic and artificial valves consisting of synthetic materials or animal tissues such as pig, cow, and human donors are used in the replacement process.
Request for a free sample copy of this report: https://www.imarcgroup.com/aortic-valve-replacement-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The growing prevalence of valvular illnesses such as aortic stenosis and aortic regurgitation is driving the worldwide aortic valve replacement market. As valves narrow and stiffen with age, the aging population has boosted the demand for aortic valve replacement technologies. Aside from that, governments in many countries are launching campaigns to raise awareness about valve replacement surgery and provide patients with high reimbursement rates. The European Association of Percutaneous Cardiovascular Interventions, for example, has created The Valve for Life Initiative to provide access to aortic valve replacement throughout Europe. Furthermore, technical advances in replacement operations and minimally invasive (MI) techniques are driving market expansion.
Breakup by Surgery:
- Open Surgery
- Minimally Invasive Surgery
Breakup by Product:
- Transcatheter Aortic Valve
- Sutureless Valve
Breakup by End Use:
- Ambulatory Surgery Centers
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- Anteris Technologies Ltd.
- Boston Scientific Corporation
- Coroneo Inc.
- CryoLife Inc.
- Edward Lifesciences Corporation
- JenaValve Technology Inc.
- LifeNet Health Inc.
- LivaNova PLC
- Medtronic plc
- Thubrikar Aortic Valve Inc.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/aortic-valve-replacement-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800